Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 84 (RPL21P84) is a processed pseudogene corresponding to the ribosomal protein L21 gene. It does not encode a protein and has no known function. Multiple pseudogenes for ribosomal proteins like L21 exist throughout the genome, generally as transcriptionally inactive sequences generated by reverse transcription of mRNA from the canonical gene and subsequent integration into new genomic locations. RPL21P84, specifically, is annotated in the human genome (Gene ID: 100271187) and is not associated with any known disease phenotype or biological function. RPL21P84 is not a molecular target, druggable gene, or biomedical receptor; it is a pseudogene, and thus, entries related to targeting, function, or disease associations should be considered null or inapplicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 84 (RPL21P84).